ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Correlating Histology, Immunohistochemical, & Serologic Data in Heart Transplant Recipients: Implications for Molecular Diagnostic Assays

P. Randhawa, Y. Huang

University of Pittsburgh Medical Center, Pittsburgh, PA

Meeting: 2022 American Transplant Congress

Abstract number: 1130

Keywords: Heart, Histology, Outcome, Rejection

Topic: Clinical Science » Heart » 63 - Heart and VADs: All Topics

Session Information

Session Name: Heart and VADs: All Topics

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: The ISHLT classification of rejection in heart allograft biopsies is independent of DSA status. There is only limited data on the prevalence of DSA in biopsies falling into specific histologic diagnostic categories for T-cell mediated rejection (TCMR) and antibody mediated rejection (AMR). The extent to which a random section taken from the tissue block for molecular studies reflects the overall pathologic diagnosis has also not been formally evaluated.

*Methods: Heart allograft biopsies obtained for clinical diagnostic purposes were subjected to a standard histopathologic examination. In-situ complement deposition was evaluated by immunohistochemistry for C4d. Medical records were reviewed for the presence of class I and class II anti-HLA donor specific antibodies (DSA) in the same time frame as the biopsy.

*Results: Examining 1 of 3 available tissue sections from 211 biopsies led to differences of at least one ISHLT 1990 rejection grade in 10% of biopsies with Quilty lesions, 42% with grade 1R, 13% with grade 2R and 31% with antibody mediated rejection grade pAMR (2) (Figure 1). A positive DSA test was obtained in 15/49 (31%) of TCMR grade 1R, 15/51 (29%) of grade 2R, 33/39 (85%%) of pAMR (1h+), and 23/27 (85%) of pAMR 2 biopsies. DSA test was negative in 62/72 (86%) pAMR (1i+) biopsies, but these could represent incipient AMR since 20/72 (28%) patients became DSA positive on subsequent follow up.

*Conclusions: (1). Rejection associated lesions are not uniformly distributed in myocardial tissue sections. This can explain why in some molecular studies that analyze limited biopsy tissue (eg PMID 28662985) up to 44% of grade 2/3 TCMRs are interpreted as ‘No Rejection’ and the corresponding archetype score is almost as high as that for histologic ABMR (0.36 vs 0.39). (2). Biopsies with histologic TCMR have concurrent DSA positivity in 29-31% biopsies, and these should be excluded from training sets used to develop molecular classifiers. (3) pAMR (1h+) biopsies may represent C4d negative ABMR in 85% of samples.

Fig. 1 Differences in degree & localization of inflammation across different biopsy fragments (upper panel). Biopsy sites, pericardium, intramyocardial fat, chordae tendineae & papillary muscle tissue can further confound the results of molecular analysis of randomly chosen tissue fragments (lower panel).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Randhawa P, Huang Y. Correlating Histology, Immunohistochemical, & Serologic Data in Heart Transplant Recipients: Implications for Molecular Diagnostic Assays [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/correlating-histology-immunohistochemical-serologic-data-in-heart-transplant-recipients-implications-for-molecular-diagnostic-assays/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences